This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grande, P. Articles by Christensen, M. S. Search for Related Content PubMed PubMed Citation Articles by Grande, P. Articles by Christensen, M. S. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Attack

Circulation, Vol 61, 723-728, Copyright © 1980 by American Heart Association

ARTICLES

Optimal diagnosis in acute myocardial infarction. A cost-effectiveness study

P Grande, C Christiansen, A Pedersen and MS Christensen

The predictive value of a diagnostic test estimates the likelihood for presence or absence of disease in a patient with a positive or negative test result (PVpos or PVneg). We evaluated the predictive values of serum activities of the heart-specific creatine kinase isoenzyme MB (CK- MB), aspartate aminotransferase, lactate dehydrogenase, CK, and ECG in 401 consecutively admitted patients suspected of acute myocardial infarction (AMI). The study showed that CK-MB (PVpos = 0.98, PVneg = 1.00) was better than the other enzymes (single as well as serial) and ECG, evaluated both separately and in combinations. In all cases of AMI CK-MB was positive within 17 hours from admission. Replacement of the standard enzymes with CK-MB provides a faster and safer diagnosis of AMI and reduces hospitalization time considerably for patients without AMI.

This article has been cited by other articles:

				H Dominguez, C Torp-Pedersen, L Koeber, and C Rask-Madsen Prognostic value of exercise testing in a cohort of patients followed for 15 years after acute myocardial infarction Eur. Heart J., February 2, 2001; 22(4): 300 - 306. [Abstract] [PDF]

				Y. Ishikawa, J. E. Saffitz, T. L. Mealman, A. M. Grace, and R. Roberts Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma Clin. Chem., March 1, 1997; 43(3): 467 - 475. [Abstract] [Full Text] [PDF]

				A. E. Abdelmeguid, E. J. Topol, P. L. Whitlow, S. K. Sapp, and S. G. Ellis Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions Circulation, October 1, 1996; 94(7): 1528 - 1536. [Abstract] [Full Text]

				I. S. Udvarhelyi, G. A. Colditz, A. Rai, and A. M. Epstein Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature: Are the Methods Being Used Correctly? Ann Intern Med, February 1, 1992; 116(3): 238 - 244. [Abstract] [PDF]

				J. E. MULLER, R. E. RUDE, E. BRAUNWALD, T. D. HARTWELL, R. ROBERTS, B. E. SOBEL, C. RITTER, C. B. PARKER, A. S. JAFFE, P. H. STONE, et al. Myocardial Infarct Extension: Occurrence, Outcome, and Risk Factors in the Multicenter Investigation of Limitation of Infarct Size Ann Intern Med, January 1, 1988; 108(1): 1 - 6. [Abstract] [PDF]

				T. H. Lee, M. C. Weisberg, E. F. Cook, K. Daley, D. A. Brand, and L. Goldman Evaluation of Creatine Kinase and Creatine Kinase--MB for Diagnosing Myocardial Infarction: Clinical Impact in the Emergency Room Arch Intern Med, January 1, 1987; 147(1): 115 - 121. [Abstract] [PDF]

				T. H. LEE and L. GOLDMAN Serum Enzyme Assays in the Diagnosis of Acute Myocardial InfarctionRecommendations Based on a Quantitative Analysis Ann Intern Med, August 1, 1986; 105(2): 221 - 233. [Abstract] [PDF]

				J. Y. Wei, J. E. Markis, M. Malagold, and W. Grossman Time Course of Serum Cardiac Enzymes After Intracoronary Thrombolytic Therapy: Creatine Kinase, Creatine Kinase MB Isozyme, Lactate Dehydrogenase, and Serum Glutamic-Oxaloacetic Transaminase Arch Intern Med, September 1, 1985; 145(9): 1596 - 1600. [Abstract] [PDF]

				J. S. Alpert Serum Enzyme Determination in Patients With Suspected Myocardial Infarction Arch Intern Med, August 1, 1983; 143(8): 1522 - 1523. [Abstract] [PDF]

				M. L. Fisher, M. H. Kelemen, D. Collins, F. Morris, G. W. Moran, N. H. Carliner, and G. D. Plotnick Routine Serum Enzyme Tests in the Diagnosis of Acute Myocardial Infarction: Cost-Effectiveness Arch Intern Med, August 1, 1983; 143(8): 1541 - 1543. [Abstract] [PDF]

				M. L. Fisher, N. H. Carliner, L. C. Becker, R. W. Peters, and G. D. Plotnick Serum Creatine Kinase in the Diagnosis of Acute Myocardial Infarction: Optimal Sampling Frequency JAMA, January 21, 1983; 249(3): 393 - 394. [Abstract] [PDF]